Q1 FY2027 · ended Sep 30, 2026 · Revenue $20.56M, +11.0% YoY · Filed Oct 29, 2026
Pro-Dex, Inc. (PDEX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q1 of fiscal 2027, the quarter ended Sep 30, 2026, it reported revenue of $20.6 million and net income of $3.0 million. Free cash flow was $6.1 million. As of Sep 30, 2026 it held $13.1 million in cash and investments and $2.5 million in total debt.
Revenue
$20.56M
+11.0% vs year-ago quarter
Net income
$3.05M
-34.9% vs year-ago quarter
Operating cash flow
$6.49M
+181.0% vs year-ago quarter
Free cash flow
$6.14M
+177.8% vs year-ago quarter
EPS
$0.92
-34.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
3.20M
-1.9% vs year-ago quarter
Net cash
$10.59M
Q1 FY2027
Operating margin
16.8%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PDEX (Nasdaq)
- Fiscal year ends
- June 30
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 788920
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Sep 30, 2026 |
Q4 FY2026 Jun 30, 2026 |
Q3 FY2026 Mar 31, 2026 |
Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $20.6M | $20.4M | $19.9M | $18.7M | $18.5M |
| Operating income | $3.5M | $3.5M | $3.1M | $3.3M | $3.1M |
| Net income | $3.0M | $2.9M | $3.9M | $2.2M | $4.7M |
| Diluted EPS | $0.92 | $0.85 | $1.20 | $0.66 | $1.40 |
| Operating cash flow | $6.5M | -$273,000 | $1.6M | $3.6M | $2.3M |
| Free cash flow | $6.1M | -$476,000 | $1.5M | $3.5M | $2.2M |
| Total assets | $76.6M | $74.5M | $75.0M | $62.3M | $64.3M |
| Total liabilities | $27.2M | $26.9M | $29.8M | $20.6M | $22.8M |
| Stockholders' equity | $49.3M | $47.6M | $45.2M | $41.6M | $41.5M |
| Cash and investments | $13.1M | $9.5M | $8.1M | $6.3M | $10.2M |
| Total debt | $2.5M | $18.1M | $1.7M | $939,000 | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| ARS | Annual report to shareholders | Oct 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 18, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 3, 2026 | Sep 3, 2026 |
All 1000 Pro-Dex, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.